Mevalone Approval in California - Powdery Mildew | 13-May-2025 | 07:00 | RNS |
Holding(s) in Company | 06-May-2025 | 12:08 | RNS |
Preliminary results for the year ended 31 Dec 2024 | 06-May-2025 | 07:00 | RNS |
Thymol Supply Agreement For Bee Health | 10-Apr-2025 | 07:00 | RNS |
Director/PDMR Shareholdings | 01-Apr-2025 | 10:08 | RNS |
Appointment of Distribution Partner in Kenya | 24-Mar-2025 | 07:00 | RNS |
Appointment of Joint Broker | 10-Mar-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 05-Mar-2025 | 12:52 | RNS |
Director/PDMR Shareholding | 05-Mar-2025 | 07:00 | RNS |
Director/PDMR Shareholdings | 04-Mar-2025 | 14:13 | RNS |
Director/PDMR Shareholding | 06-Feb-2025 | 14:08 | RNS |
Director/PDMR Shareholdings | 28-Jan-2025 | 10:36 | RNS |
Trading Update | 13-Jan-2025 | 07:12 | RNS |
Regulatory approval for Novellus+ in Mexico | 20-Dec-2024 | 07:00 | RNS |
Appointment of Distributor in Austria | 16-Dec-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 3.90p |
Change Today | -0.15p |
% Change | -3.70 % |
52 Week High | 4.90 |
52 Week Low | 2.35 |
Volume | 323,037 |
Shares Issued | 533.35m |
Market Cap | £20.80m |
Beta | 0.05 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
12:37 | 52,430 @ 3.83p |
12:28 | 57,892 @ 3.83p |
11:58 | 100,000 @ 3.90p |
08:47 | 5,000 @ 3.90p |
08:34 | 200 @ 3.90p |
CFO | Alexander John Abrey |
CEO | Sean M. Smith |
You are here: research